









Enzerna Biosciences, a pre-clinical stage company, uses ASREs to combat nucleotide expansion disorders.

IRR, a US-based company, develops pharmaceutical products to treat inflammatory disorders.

Ionis Pharmaceuticals: A US-based biotech firm specializing in RNA-targeted drug discovery for unmet needs.

Expansion Therapeutics: Innovating small molecule medicines for RNA-mediated diseases.

Korro Bio: Innovating extraordinary treatments for patient care.

ADURO, Inc.: A clinical-stage biopharmaceutical firm offering talent management and culture-building services.

Advirna, a US-based biotech firm, innovates efficient in-vivo polynucleotide delivery using RNA interference.

Seattle-based AVM is a biotech firm innovating in stem cell technologies for regenerative medicine and cancer recovery.

Ambulero: A University of Miami spin-out advancing cell and gene therapies to combat vascular disease.

Biobot Analytics develops a wastewater intelligence platform that converts sewage measurements into predictive public-health signals.

US-based Cogent Biosciences develops biotech solutions for genetically driven diseases.

Ochre Bio: Biotech firm creating RNA meds & platforms for liver health.

Stanford-based AIRNA pioneers RNA editing therapies for rare and common health ailments.

ReviR Therapeutics: A genomics-based platform for developing innovative RNA-targeting medicines.

Cornell University: A private, Ivy League research institution in Ithaca, NY, with a diverse student body.

Online course provider founded by Harvard and MIT offering university-level courses.

Coursera, Inc.: A global online education platform partnering with universities for diverse classes.

Encoded: Leveraging human genome power for effective precision therapies in genetic disorders.

FibroGen, Inc: A global, research-based pharmaceutical company in San Francisco, innovating treatments for unmet medical needs.

Gilead Sciences: An American biopharmaceutical firm innovating therapies for critical diseases.